title: Rifampicin and moxifloxacin for tuberculous meningitis--authors' reply.
authors.affiliation: Department of Pharmacology and Therapy, Padjadjaran University, Hasan Sadikin Hospital, Bandung, Indonesia.
authors.forename: Rovina
authors.initials: R
authors.lastname: Ruslami
authors.affiliation: Department of Neurology, Padjadjaran University, Hasan Sadikin Hospital, Bandung, Indonesia.
authors.forename: A Rizal
authors.initials: AR
authors.lastname: Ganiem
authors.affiliation: Department of Pharmacy, Radboud University Medical Centre, Nijmegen, Netherlands.
authors.forename: Rob E
authors.initials: RE
authors.lastname: Aarnoutse
authors.affiliation: Department of Medicine, Radboud University Medical Centre, Nijmegen, Netherlands. Electronic address: r.vancrevel@aig.umcn.nl.
authors.forename: Reinout
authors.initials: R
authors.lastname: van Crevel
mesh_terms: D000995:Antitubercular Agents / Q000008:administration & dosage*; D001372:Aza Compounds / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D011804:Quinolines / Q000008:administration & dosage*; D012293:Rifampin / Q000008:administration & dosage*; D014390:Tuberculosis, Meningeal / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D001372:Aza Compounds; D011804:Quinolines; D012293:Rifampin